Literature DB >> 15804466

Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.

Anne Marie Wallace1, Bruce L Daniel, Stefanie S Jeffrey, Robyn L Birdwell, Kent W Nowels, Frederick M Dirbas, Pamela Schraedley-Desmond, Debra M Ikeda.   

Abstract

BACKGROUND: We performed this study to determine rates of close or transected cancer margins after magnetic resonance imaging-guided bracket wire localization for nonpalpable breast lesions. STUDY
DESIGN: Of 243 women undergoing MRI-guided wire localizations, 26 had MRI bracket wire localization to excise either a known cancer (n = 19) or a suspicious MRI-detected lesion (n = 7). We reviewed patient age, preoperative diagnosis, operative intent, mammographic breast density, MRI lesion size, MRI enhancement curve and morphology, MRI Breast Imaging Reporting and Data System (BI-RADS) assessment code, number of bracket wires, and pathology size. We analyzed these findings for their relationship to obtaining clear margins at first operative excision.
RESULTS: Twenty-one of 26 (81%) patients had cancer. Of 21 patients with cancer, 12 (57%) had negative margins at first excision and 9 (43%) had close/transected margins. MRI size > or = 4 cm was associated with a higher reexcision rate (7 of 9, 78%) than those < 4 cm (2 of 12, 17%) (p = 0.009). MRI BI-RADS score, enhancement curve, morphology, and preoperative core biopsy demonstrating ductal carcinoma in situ (DCIS) were not predictive of reexcision. The average number of wires used for bracketing increased with lesion size, but was not associated with improved outcomes. On pathology, cancer size was smaller in patients with negative margins (12 patients, 1.2 cm) than in those with close/transected margins (9 patients, 4.6 cm) (p < 0.001). Reexcision was based on close/transected margins involving DCIS alone (6, 67%), infiltrating ductal carcinoma and DCIS (2, 22%), or infiltrating ductal carcinoma alone (1, 11%). Reexcision pathology demonstrated DCIS (3, 33%), no residual cancer (5, 55%), and 1 patient was lost to followup (1, 11%). Interestingly, cancer patients who required reexcision were younger (p = 0.022), but breast density was not associated with reexcision.
CONCLUSIONS: To our knowledge, this is the first report of MRI-guided bracket wire localization. Patients with MRI-detected lesions less than 4 cm had clear margins at first excision; larger MRI-detected lesions were more likely to have close/transected margins. Reexcision was often because of DCIS and was the only pathology found at reexcision, perhaps because MRI is more sensitive for detecting invasive carcinoma than DCIS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804466     DOI: 10.1016/j.jamcollsurg.2004.12.013

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Impact of value based breast cancer care pathway implementation on pre-operative breast magnetic resonance imaging utilization.

Authors:  Devina K S McCray; Stephen R Grobmyer; Holly J Pederson
Journal:  Gland Surg       Date:  2017-02

2.  Toward MR-guided high intensity focused ultrasound for presurgical localization: focused ultrasound lesions in cadaveric breast tissue.

Authors:  Rachel R Bitton; Elena Kaye; Frederick M Dirbas; Bruce L Daniel; Kim Butts Pauly
Journal:  J Magn Reson Imaging       Date:  2011-12-14       Impact factor: 4.813

3.  Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit?

Authors:  Kathryn L Davis; Richard J Barth; Jiang Gui; Elizabeth Dann; Burton Eisenberg; Kari Rosenkranz
Journal:  Ann Surg Oncol       Date:  2012-08-22       Impact factor: 5.344

Review 4.  Current Controversies on the Use of Magnetic Resonance Imaging in the Management of Breast Cancer.

Authors:  Edibaldo Silva
Journal:  World J Oncol       Date:  2011-06-08

5.  Surgical outcome of patients with core-biopsy-proven nonpalpable breast carcinoma: a large cohort follow-up study.

Authors:  S van Esser; N H G M Peters; M A A J van den Bosch; W P Th M Mali; P H M Peeters; I H M Borel Rinkes; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2009-05-13       Impact factor: 5.344

6.  Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes.

Authors:  Giang H T Au; Wan Y Shih; Wei-Heng Shih; Linette Mejias; Vanlila K Swami; Kimberly Wasko; Ari D Brooks
Journal:  Int J Surg Oncol       Date:  2012-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.